Violence Against Women and Girls in the UK: A Growing Epidemic
The National Audit Office has slammed the UK government's efforts to tackle violence against women and girls (VAWG), calling it a
Submarine Name Change Stirs Controversy: Agincourt to Achilles
Why the sudden change of name for a new attack submarine? Downing Street defends the decision to rename the HMS Agincourt to HMS Achilles, after critics accused ministers of trying not to upset the French. But not everyone's happy with this change, with former navy officers and defense secretaries accusing the government of erasing history and tradition. What's behind this name change? Here's what you need to know.
Teen Faces Decades in Prison for Taylor Swift-Themed Event Stabbing
What was supposed to be a fun Taylor Swift-themed dance class turned into a horrific scene when a violence-obsessed teenager, Axel Rudakubana, attacked two dozen young girls, killing three and injuring several more. The attack triggered anti-immigrant rioting and has led the government to reconsider its definition of terrorism. Rudakubana, who was born in Cardiff, Wales to Christian parents from Rwanda, faces a sentencing hearing on Thursday.
Multiple Shocking Incidents on Christmas Day Across the UK
Three Disturbing Incidents Shock the UK on Christmas Day:**
1. A 50-year-old man was found dead in Northern Ireland, leading to a murder investigation.
2. A man drove a car into a group of people in London's West End, resulting in four people being taken to the hospital.
3. A man was charged with murdering two women in Milton Keynes.
Stay informed and stay safe.
UK Bans Puberty Blockers for Under-18s with Gender Dysphoria: A Comprehensive Summary
Puberty blockers for under-18s with gender dysphoria have been banned indefinitely in the UK, following official advice from medical experts. The government said that the way the drugs had been used was a 'scandal', with children being prescribed the treatment after only one online consultation. The Commission on Human Medicines found that the current prescribing and care pathway for gender dysphoria presents an unacceptable safety risk for children and young people. A clinical trial into the use of puberty blockers will be established next year to establish a clear evidence base for the use of this medicine. The ban has been welcomed by some, but criticized by others as 'discrimination'.
